Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

S. STEFFENS ; N. R. VEILLARD ; C. ARNAUD ; PELLI G. ; F. BURGER ; C. STAUB ; A. ZIMMER ; FROSSARD J. L. ; MACH F. | 2005
Dans Nature (Vol.434, n°7034, 7 April 2005) Article : Périodique

Atherosclerosis is a chronic inflammatory disease, and is the primary cause of heart disease and stroke in Western countries. Derivatives of cannabinoids such as delta-9-tetrahydrocannabinol (THC) modulate immune functions and therefore have pot[...]

Plus d'info

Ajouter à la sélection